About: covid:498cc1e1dfb7d2f3933a1fe58409156ec4297857

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:498cc1e1dfb7d2f3933a1fe58409156ec4297857 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Hunsberger, Sally Llamosas-Gallardo, Beatriz Moreno-Espinosa, Sarbelio Ramirez-Venegas, Alejandra Beigel, John Freimanis-Hance, Laura Magaña-Aquino, Martin Nishimura, Katherine Paulin-Prado, Paulina Galindo Fraga, Arturo Ortiz Hernandez, Ana Ruiz Palacios, Guillermo
is schema:about of	named entity 'assigned' named entity 'hospitalization' named entity 'Muscle pain' named entity 'risk factor' named entity 'complications' named entity 'asthma' named entity 'ASSOCIATED WITH' named entity 'TRIGGER ASTHMA' named entity 'PROPORTION' named entity 'KNOWN' named entity 'BASED' named entity 'ASSIGNED' named entity 'COMPLICATIONS' named entity 'PREDICT' named entity 'CHRONIC' named entity 'DELAY' named entity 'BACKGROUND' named entity 'LUNG DISEASES' named entity 'AT HIGHER RISK' named entity 'WHEEZING' named entity 'VIRAL ILLNESS' named entity 'MEXICO' named entity 'ILI' named entity 'OBJECTIVE' named entity 'ASTHMA' named entity '46-5' named entity 'INFLAMMATORY' named entity 'INFLUENZA-LIKE ILLNESS' named entity 'ASTHMATIC' named entity 'INCLUDED' named entity 'TO INVESTIGATE' named entity 'METHODS' named entity 'CONCLUSION' named entity '1.46' named entity 'MEXICO' named entity 'CLINICAL CHARACTERISTICS' named entity 'PATIENTS' named entity 'RISK OF' named entity 'SITES' named entity 'PRESENCE OF' named entity 'DID' named entity 'EXACERBATION' named entity 'PROGRESSING TO' named entity 'SYMPTOMS' named entity 'RISK FACTORS' named entity 'RISK FACTOR' named entity 'PARTICIPANTS' named entity 'BUT' named entity 'PREVIOUS' named entity 'SEVERE' named entity 'SEVERE' named entity 'ASSOCIATED' named entity 'PATIENTS' named entity 'DESCRIPTION' named entity 'TYPE' named entity 'VIRAL INFECTIONS' named entity 'REPORT' named entity 'NUMBER' named entity 'CLINICAL CHARACTERISTICS' named entity 'PRESENTED' named entity 'YEARS' named entity 'ROLE' named entity 'INFLUENZA-LIKE ILLNESS' named entity 'DIAGNOSIS' named entity 'ASTHMA EXACERBATIONS' named entity 'EARLY' named entity 'PUBLISHED' named entity 'NASAL DRIP' named entity 'HOSPITALS' named entity 'REQUIRED HOSPITALIZATION' named entity 'REPORTED' named entity 'DEFINED' named entity 'DYSPNEA' named entity 'PARTICULAR' named entity 'MEDICAL CARE' named entity 'CASES' named entity 'RESULTS' named entity 'VIRUS' named entity 'TO PREVENT' named entity 'RATIO' named entity 'VIRUSES' named entity 'LIKELY' named entity 'TOTAL' named entity 'MUSCLE PAIN' covid:arg/498cc1e1dfb7d2f3933a1fe58409156ec4297857 named entity 'prevent' named entity 'asthma' named entity 'severe'

Attributes

Values

Creator

Hunsberger, Sally
Llamosas-Gallardo, Beatriz
Moreno-Espinosa, Sarbelio
Ramirez-Venegas, Alejandra
Beigel, John
Freimanis-Hance, Laura
Magaña-Aquino, Martin
Nishimura, Katherine
Paulin-Prado, Paulina
Galindo Fraga, Arturo
Ortiz Hernandez, Ana
Ruiz Palacios, Guillermo

is schema:about of

named entity 'assigned'
named entity 'hospitalization'
named entity 'Muscle pain'
named entity 'risk factor'
named entity 'complications'
named entity 'asthma'
named entity 'ASSOCIATED WITH'
named entity 'TRIGGER ASTHMA'
named entity 'PROPORTION'
named entity 'KNOWN'
named entity 'BASED'
named entity 'ASSIGNED'
named entity 'COMPLICATIONS'
named entity 'PREDICT'
named entity 'CHRONIC'
named entity 'DELAY'
named entity 'BACKGROUND'
named entity 'LUNG DISEASES'
named entity 'AT HIGHER RISK'
named entity 'WHEEZING'
named entity 'VIRAL ILLNESS'
named entity 'MEXICO'
named entity 'ILI'
named entity 'OBJECTIVE'
named entity 'ASTHMA'
named entity '46-5'
named entity 'INFLAMMATORY'
named entity 'INFLUENZA-LIKE ILLNESS'
named entity 'ASTHMATIC'
named entity 'INCLUDED'
named entity 'TO INVESTIGATE'
named entity 'METHODS'
named entity 'CONCLUSION'
named entity '1.46'
named entity 'MEXICO'
named entity 'CLINICAL CHARACTERISTICS'
named entity 'PATIENTS'
named entity 'RISK OF'
named entity 'SITES'
named entity 'PRESENCE OF'
named entity 'DID'
named entity 'EXACERBATION'
named entity 'PROGRESSING TO'
named entity 'SYMPTOMS'
named entity 'RISK FACTORS'
named entity 'RISK FACTOR'
named entity 'PARTICIPANTS'
named entity 'BUT'
named entity 'PREVIOUS'
named entity 'SEVERE'
named entity 'SEVERE'
named entity 'ASSOCIATED'
named entity 'PATIENTS'
named entity 'DESCRIPTION'
named entity 'TYPE'
named entity 'VIRAL INFECTIONS'
named entity 'REPORT'
named entity 'NUMBER'
named entity 'CLINICAL CHARACTERISTICS'
named entity 'PRESENTED'
named entity 'YEARS'
named entity 'ROLE'
named entity 'INFLUENZA-LIKE ILLNESS'
named entity 'DIAGNOSIS'
named entity 'ASTHMA EXACERBATIONS'
named entity 'EARLY'
named entity 'PUBLISHED'
named entity 'NASAL DRIP'
named entity 'HOSPITALS'
named entity 'REQUIRED HOSPITALIZATION'
named entity 'REPORTED'
named entity 'DEFINED'
named entity 'DYSPNEA'
named entity 'PARTICULAR'
named entity 'MEDICAL CARE'
named entity 'CASES'
named entity 'RESULTS'
named entity 'VIRUS'
named entity 'TO PREVENT'
named entity 'RATIO'
named entity 'VIRUSES'
named entity 'LIKELY'
named entity 'TOTAL'
named entity 'MUSCLE PAIN'
covid:arg/498cc1e1dfb7d2f3933a1fe58409156ec4297857
named entity 'prevent'
named entity 'asthma'
named entity 'severe'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software